Keyword Connections

steatosis

Journals

1

1 Aging

Research Groups

0

No Research Group Connected

Bibliographies

37

1 GPR109A activation and aging liver.

2 how useful are monogenic rodent models for the study of human non-alcoholic fatty liver disease?

3 insulin resistance and chronic hepatitis c

4 hepatic microcirculatory failure falência microcirculatória hepática

5 current level of evidence on causal association between hepatitis c virus and type 2 diabetes: a review

6 esteato-hepatite relacionada ao vírus da hepatite c: perfil clínico-histológico steatohepatitis related to hepatitis c virus: clinical and histological profiles

7 roux-en y gastric bypass results in long-term remission of hepatocyte apoptosis and hepatic histological features of non-alcoholic steatohepatitis

8 Hesperidin improves hepatic steatosis, hepatic enzymes, and metabolic and inflammatory parameters in patients with nonalcoholic fatty liver disease: A randomized, placebo-controlled, double-blind clinical trial.

9 Chronic exposure to tetrabromodiphenyl ether (BDE-47) aggravates hepatic steatosis and liver fibrosis in diet-induced obese mice

10 Inhibiting Interleukin 11 Signaling Reduces Hepatocyte Death and Liver Fibrosis, Inflammation, and Steatosis in Mouse Models of Nonalcoholic Steatohepatitis

11 Liver MRI susceptibility-weighted imaging (SWI) compared to T2* mapping in the presence of steatosis and fibrosis

12 Formononetin alleviates hepatic steatosis by facilitating TFEB-mediated lysosome biogenesis and lipophagy.

13 Reply to "The Connection between Celiac Disease and Hepatic Steatosis: High Levels of Pigment Epithelium-Derived Factor".

14 Whole Grain Consumption and Its Effects on Hepatic Steatosis and Liver Enzymes in Patients with Nonalcoholic Fatty Liver Disease: A Randomized Controlled Clinical Trial.

15 Leptin/adiponectin ratio correlates with hepatic steatosis but not arterial stiffness in nonalcoholic fatty liver disease in Japanese population

16 Long non-coding RNA (lncRNA) H19 induces hepatic steatosis through activating MLXIPL and mTORC1 networks in hepatocytes.

17 Ginsenosides reduce body weight and ameliorate hepatic steatosis in high fat diet‑induced obese mice via endoplasmic reticulum stress and p‑STAT3/STAT3 signaling.

18 Noninvasive assessment of liver steatosis in children: the clinical value of controlled attenuation parameter

19 Regulation of CD39 expression in ATP-P2Y2R-mediated alcoholic liver steatosis and inflammation

20 Contamination of organohalogen chemicals and hepatic steatosis in common kingfisher (Alcedo atthis) breeding at a nature reserve near e-waste recycling sites in South China.

21 Links between donor macrosteatosis, interleukin-33 and complement after liver transplantation.

22 variability in myosteatosis and insulin resistance induced by high-fat diet in mouse skeletal muscles

23 trif differentially regulates hepatic steatosis and inflammation/fibrosis in micesummary

24 effects of 4-nonylphenol on oxidant/antioxidant balance system inducing hepatic steatosis in male rat

25 efficacy of acetylshikonin in preventing obesity and hepatic steatosis in db/db mice

26 pnpla3 rs1010023 predisposes chronic hepatitis b to hepatic steatosis but improves insulin resistance and glucose metabolism

27 grape seed proanthocyanidin rescues rats from steatosis: a comparative and combination study with metformin

28 rho, a fraction from rhodiola crenulate, ameliorates hepatic steatosis in mice models

29 the korean mistletoe (viscum album coloratum) extract has an antiobesity effect and protects against hepatic steatosis in mice with high-fat diet-induced obesity

30 inflammatory mediators of hepatic steatosis

31 zinc oxide nanoparticle caused plasma metabolomic perturbations correlate with hepatic steatosis

32 obesity and metabolic phenotypes (metabolically healthy and unhealthy variants) are significantly associated with prevalence of elevated c-reactive protein and hepatic steatosis in a large healthy brazilian population

33 effect of dietary cocoa tea (camellia ptilophylla) supplementation on high-fat diet-induced obesity, hepatic steatosis, and hyperlipidemia in mice

34 pparα is required for pparδ action in regulation of body weight and hepatic steatosis in mice

35 nuciferine downregulates per-arnt-sim kinase expression during its alleviation of lipogenesis and inflammation on oleic acid-induced hepatic steatosis in hepg2 cells

36 treatment with lobeglitazone attenuates hepatic steatosis in diet-induced obese mice

37 Viscosol Treatment Ameliorates Insulin-Mediated Regulation of Dyslipidemia, Hepatic Steatosis, and Lipid Metabolism by Targeting PTP1B in Type-2 Diabetic Mice Model.